Derick Raal, Head of Lipidology and Endocrinology at Johannesburg Hospital, South Africa, anticipates research to further understand possible targets for ANGPTL3 and apoCIII inhibition, and outcome studies to establish their effects on cardiovascular events.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
